Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2	Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracerebral hemorrhage, nervous system disorder, vascular disorder	Recruiting	Phase 3	2026-08-20		NCT07227246

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Japan Agency for Medical Research and Development	11
Joseph Broderick, MD	2
National Institute of Neurological Disorders and Stroke (NINDS)	370
Novo Nordisk A/S	181

89 results · Page 1 of 4

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Arnau de Vilanova University Hospital	Lleida	Spain	3
Barnes Jewish Hospital	St Louis	United States	16
Bellvitge University Hospital,	L'Hospitalet de Llobregat	Spain	2
Central DuPage Hospital	Winfield	United States	6
Charite University Medicine Berlin	Berlin	Germany	2
Clinic Frankfurt Hoechst	Frankfurt am Main	Germany	2
Gifu University Hospital	Gifu	Japan	8
Girona University Hospital	Girona	Spain	2
Grady Memorial Hospital	Atlanta	United States	41
Hamilton General Hospital	Hamilton	Canada	38
Health Sciences Centre Winnipeg	Winnipeg	Canada	7
Henry Ford Hospital	Detroit	United States	3
Hospital Universitari Germans Trias i Pujol	Badalona	Spain	2
Japanese Red Cross Kyoto Daini Hospital	Kyoto	Japan	5
Jichi Medical University Hospital	Shimotsuke	Japan	5
John Radcliffe Hospital	Oxford	United Kingdom	15
Kagoshima City Hospital	Kagoshima	Japan	3
Kaiser Permanente Baldwin Park Medical Center	Baldwin Park	United States	5
Kaiser Permanente Downey Medical Center	Downey	United States	61
Kaiser Permanente Fontana Medical Center	Fontana	United States	9
Kaiser Permanente Los Angeles Medical Center	Los Angeles	United States	134
Kaiser Permanente Riverside Medical Center	Riverside	United States	7
Kaiser Permanente South Bay Medical Center	Harbor City	United States	5
Kaiser Permanente West Los Angeles Medical Center	Los Angeles	United States	5
KMU University Hospital	Osaka	Japan	2

Clinical trials